Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AF35700 PK with Itraconazole in Healthy Subjects
NCT03103646Phase 1Completed
- Sponsor
- Lundbeck
- Start
- Mar 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label trial of lu af35700 in schizophrenia (2 arms), sponsored by Lundbeck. Primary endpoints: Area Under the Curve from time zero to infinity at Day 32 and Maximum Plasma Concentration at Day 32. Started Mar 2017; status: completed.
02
Drugs
lu af35700
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03103646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103646.